Skip to main content

NOMURA HOLDINGS INC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1163653 TOKYO, M0

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
5 quarters on record

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Derivatives in BCRX

reported options exposure · as of Jun 30, 2026
CallValue
$361,000
CallShares
36,100
PutValue
$500,000
PutShares
50,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

NOMURA HOLDINGS INC holds $203,047,916 across 12 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in BCRX

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $361,000 36,100
2026-06-30 $500,000 50,000
2026-03-31 $903,448 94,900
2026-03-31 $903,448 94,900
2025-12-31 $319,800 41,000
2025-12-31 $319,800 41,000
2022-12-31 $15,248,780 1,328,291
2022-09-30 $3,575,968 283,807